GL1X · GenesisL1 explorer

MolNFT v1 · #189781 · protein

SARS-cov-2 3CL protease (3CLPRO) in complex with a covalent inhibitor

7VVT · 3C-like proteinase: “SARS-cov-2 3CL protease (3CLPRO) in complex with a covalent inhibitor”. X-ray diffraction, 1 ligand (80X), 7 pockets (best druggability 0.76). MolNFT v1 #189781 on GenesisL1: 3D structure, binding sites and…

PDB
7VVT
Type
protein
Length
586 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
80X
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30025% helix, 29% strandP0DTC1
B3C-like proteinase (EC 3.4.22.69)protein28626% helix, 31% strandP0DTC1

Ligands and binding sites

  • 80X · N-(3-chlorophenyl)-2-[(2R)-1-ethanoyl-3-oxidanylidene-piperazin-2-yl]ethanamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111060.760.78108empty
2550.560.8916empty
3950.530.8424empty
41800.500.772980X
51340.490.7925empty

Interfaces

1 interface between chains.

  • A–B · 1259 Ų buried · 33 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7VVT · SARS-CoV-2 3CL protease (3CLpro) in complex with a covalent inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.